Clofarabine does not negatively impact the outcomes of patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.

[1]  L. Silverman,et al.  Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia. , 2010, Blood.

[2]  M. Tsubokura,et al.  Cytarabine dose for acute myeloid leukemia. , 2011, The New England journal of medicine.

[3]  Allen R. Chen,et al.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Bob Löwenberg,et al.  Review Articles (434 articles) , 2008 .

[5]  H. Döhner,et al.  High-dose daunorubicin in older patients with acute myeloid leukemia. , 2009, The New England journal of medicine.

[6]  M. Patnaik,et al.  Anthracycline dose intensification in acute myeloid leukemia. , 2009, The New England journal of medicine.

[7]  J. Byrd,et al.  Acute myeloid leukemia clinical practice guidelines in oncology. , 2006, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  H. Kantarjian,et al.  The role of clofarabine in hematologic and solid malignancies—Development of a next‐generation nucleoside analog , 2005, Cancer.

[9]  R. Stone,et al.  Acute myeloid leukemia. , 2012, Hematology. American Society of Hematology. Education Program.

[10]  V. Gandhi,et al.  Biochemical modulation of cytarabine triphosphate by clofarabine , 2005, Cancer Chemotherapy and Pharmacology.

[11]  P. Richardson,et al.  Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. , 2003, Blood.

[12]  R. Mayer,et al.  Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. , 1994, The New England journal of medicine.

[13]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[14]  Pankaj Sharma,et al.  Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors , 1984, Hepatology.